- Brand name:
- Pharmaceutical Company:
- Condition/Indication: Fabry disease
- Meeting Date: December 2022
- Public Summary Document (PSD) December 2022 PBAC Meeting - (PDF 456KB)
- Public Summary Document (PSD) December 2022 PBAC Meeting - (Word 77KB)
Migalastat – December 2022
Migalastat: Capsule containing migalastat hydrochloride 150 mg; Galafold® – December 2022
Last updated
7 July 2025